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O
ver the past several years, the editors of leading international car-
diovascular journals have met to form the HEART Group and to
discuss areas of growing common interest. Recently, the HEART
Group has developed a document that addresses general ethics princi-
ples in the conduct of the scientific process with which all of the edi-
tors concur. Published essentially simultaneously in all of the
participating journals, including this journal, this document presents
the ethical tenets accepted by all of the undersigned editors that will
(continue to) guide their decisions in the editorial process.
These are the general principles on which the HEART Group is
based and by which we, as a group, abide. However, please note that
individual journal members and their respective societies may have
their own rules and regulations that supersede the guidelines of the
HEART Group.
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The purpose of this is to ensure transparency and honesty in the sci-
entific process that promotes ethical conduct in the performance and
publication of research. The following will be considered as parts of
this process: 
• Disclosure of potential conflicts of interest for all involved in
the performance of research and in the evaluation and
publication process of a manuscript. Relevant relationships with
commercial interests will be defined in terms of levels and
nature of support. The nature of support will be listed as grants,
supplies/equipment, type of employment or personal income.
Equity and royalty interests should be stated, as well as any
fiduciary relationship with the sponsor. 
• Establish thorough review processes particularly alert to
discovering scientific fraud and data falsification, redundant or
duplicate publication, and plagiarism, and to adopt a uniform
standard of dealing with authors guilty of fraudulent practices.
• Maintain confidentiality and embargos where appropriate.
• Create uniform criteria to establish authorship. To qualify for
authorship, individuals must have made substantial
contributions to the intellectual content of the paper in at least
one of the following areas: conceived and designed the research;
acquired the data; analyzed and interpreted the data; performed
statistical analysis; handled funding and supervision; drafted the
manuscript; or made critical revision of the manuscript for
important intellectual content. Authors must give final approval
of the version to be submitted and any revised version to be
published. For multicentre trials, individuals who accept direct
responsibility for the manuscript should fully meet the criteria
for authorship previously defined; contributors not meeting
these criteria should be acknowledged.
• Note avoidance of false claims of ownership and priority by
attention to previous publications.
• Establish avoidance of excessive claims of benefits of a
product/technique in the publication, as well as with news
media.
• Note compliance with institutional review board requirements
and, when appropriate, approved laboratory procedures for
animal research, and that the research conforms to the ethical
standards of the Declaration of Helsinki, the Geneva
Declaration, the Belmont Report and Good Clinical Practices
from the FDA, and that the submission conforms to the
International Committee of Medical Journal Editors (ICMJE)
“Uniform Requirements for Manuscripts Submitted to
Biomedical Journals: Writing and Editing for Biomedical
Publication” (www.ICMJE.org).
